Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03250988 · ClinicalTrials.gov registry record
Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 60
- Enrollment target
NCT03250988: Completed study, sponsored by Vanderbilt University Medical Center.
NCT03250988 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03250988 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to improve spasticity diagnosis through exploration of potential new diagnostic markers for spasticity that can assist in diagnosis and referral.
Primary Outcome
Prevalence of spasticity will be determined by recording the presence/absence of spasticity based on the neurological examination performed on all consenting residents of the long-term care facility. Prevalence of urinary incontinence will be determined by medical record review of all consenting residents of the long-term care facility. The research coordinator will report prevalence of comorbid spasticity and incontinence as a descriptive statistic.
Interventions
- DIAGNOSTIC_TEST Neurological Examination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-01-30 |
| Est. Completion | 2018-08-01 |
What the finished NCT03250988 record still lists
NCT03250988 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Neurological Examination is the first listed.
NCT03250988 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03250988 about?
NCT03250988 is a clinical study titled "Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility". The purpose of this study is to improve spasticity diagnosis through exploration of potential new diagnostic markers for spasticity that can assist in diagnosis and referral.
What is the current status of trial NCT03250988?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2018-01-30. Estimated completion is 2018-08-01.
What interventions are being tested in trial NCT03250988?
The interventions under investigation include: Neurological Examination (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03250988?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI